Microbot Medical Submits an IDE Application to Gain FDA Approval to Commence Its Pivotal Clinical Trial in the USGlobe Newswire • 3 months ago
The Investigational Device Exemption (IDE) application follows the completion of multiple activities necessary to file this applicationBRAINTREE, Mass., Feb. 05, 2024 (GLOBE NEWSWIRE) -- Microbot...
Share to Feed
Microbot Medical (NASDAQ:MBOT Get Free Report) and Sigyn Therapeutics (OTCMKTS:SIGY Get Free Report) are both small-cap medical companies, but which is the better investment? We will...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
All of the cash payable to the plaintiffs in the settlement will be covered by Microbot's insurance carrier and will not impact company's cash positionBRAINTREE, Mass., Jan. 30, 2024 (GLOBE...
Following the recent positive results of its pivotal GLP pre-clinical study, the Company added a CRA to facilitate the company's first in human clinical studyBRAINTREE, Mass., Jan. 18, 2024 (GLOBE...
Microbot Medical (NASDAQ:MBOT Get Free Report) and NeuroMetrix (NASDAQ:NURO Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...